Washington, D.C., partner Jesse Witten served as a co-chair for the American Conference Institute’s two-day conference on “Reducing Legal and Compliance Risks in the Sales and Marketing of Medical Devices.”  On April 28, Jesse spoke on “Current Foreign Corrupt Practices Act Enforcement Initiatives and Controlling Overseas Operations.”  Jesse discussed ways that medical device companies can manage their risk to FCPA enforcement while doing business effectively overseas.
Source: American Conference Institute